Remove Networking Remove Pharma Remove Pharmaceutical products Remove White Paper
article thumbnail

Inflationary storm clouds will continue to buffet global pharma industry in 2023

Pharmaceutical Technology

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.

Pharma 64
article thumbnail

Inflationary storm clouds will continue to buffet global pharma industry in 2023

Pharmaceutical Technology

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. Consumers are taking notice of these metrics, and there is demand for action from pharma.

Pharma 142
article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Pharma 52